Thymosin β4: A potential molecular target for tumor therapy

Critical Reviews in Eukaryotic Gene Expression

Volumn 22, Issue 2, 2012, Pages 109-116

  Xiao, Yongtao ^a   Chen, Yingwei ^a,b   Wen, Jie ^a   Yan, Weihui ^a   Zhou, Kejun ^a   Cai, Wei ^a,b  

^a Shanghai Institute of Pediatric Research   (China)

^b XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Actin sequestering; Cancer therapy; Cell migration; Inflammation; Thymosin 4

Indexed keywords

ANGIOGENIC FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MATRILYSIN; REACTIVE OXYGEN METABOLITE; THYMOSIN BETA4; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CANCER THERAPY; CELL ADHESION; CELL SURVIVAL; CELL TRANSPORT; EPITHELIAL MESENCHYMAL TRANSITION; EXON; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; IMMUNOREACTIVITY; INFLAMMATORY CELL; INTRON; METASTASIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TISSUE REGENERATION; WOUND HEALING;

ANIMALS; CELL MOVEMENT; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; THYMOSIN; WOUND HEALING;

EID: 84865636011     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukarGeneExpr.v22.i2.30     Document Type: Article

References (55)

1. Nagamalleswari K, Safer D. Sequestered actin in chick embryo fibroblasts. Mol Cell Biochem. 2000;209(1-2):63-7.
2. Reti R, Kwon E, Qiu P, Wheater M, Sosne G. Thymosin beta4 is cytoprotective in human gingival fibroblasts. Eur J Oral Sci. 2008;116(5):424-30.
3. Grant DS, Rose W, Yaen C, Goldstein A, Martinez J, Kleinman H. Thymosin beta4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis. 1999;3(2):125-35.
4. Mollinari C, Ricci-Vitiani L, Pieri M, Lucantoni C, Rinaldi AM, Racaniello M, De Maria R, Zona C, Pallini R, Merlo D, Garaci E. Downregulation of thymosin beta4 in neural progenitor grafts promotes spinal cord regeneration. J Cell Sci. 2009;122(Pt 22):4195-207.
5. Mu H, Ohashi R, Yang H, Wang X, Li M, Lin P, Yao Q, Chen C. Thymosin beta10 inhibits cell migration and capillary-like tube formation of human coronary artery endothelial cells. Cell Motil Cytoskeleton. 2006;63(4):222-30.
6. Roy P, Rajfur Z, Jones D, Marriott G, Loew L, Jacobson K. Local photorelease of caged thymosin beta4 in locomoting keratocytes causes cell turning. J Cell Biol. 2001;153(5):1035-48.
7. Philp D, Huff T, Gho YS, Hannappel E, Kleinman HK. The actin binding site on thymosin beta4 promotes angiogenesis. FASEB J. 2003;17(14):2103-5.
8. Francis Godschalk M. Pressure ulcers: a role for thymosin beta4. Ann N Y Acad Sci.2007;1112:413-7.
9. Smart N, Rossdeutsch A, Riley PR. Thymosin beta4 and angiogenesis: modes of action and therapeutic potential. Angiogenesis. 2007;10(4):229-41.
10. Philp D, Nguyen M, Scheremeta B, St-Surin S, Villa AM, Orgel A, Kleinman HK, Elkin M. Thymosin beta4 increases hair growth by activation of hair follicle stem cells. FASEB J. 2004;18(2):385-7.
11. Caers J, Otjacques E, Hose D, Klein B, Vanderkerken K. Thymosin beta4 in multiple myeloma: friend or foe. Ann N Y Acad Sci. 2010;1194:125-9.
12. Low TL HS, Goldstein AL. Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc Natl Acad Sci U S A. 1981;78(2):1162-6.
13. Yang SP, Lee HJ, Su Y. Molecular cloning and structural characterization of the functional human thymosin beta4 gene. Mol Cell Biochem. 2005;272(1-2):97-105.
14. Domanski M HM, Coutant J, Gutsche-Perelroizen I, Bontems F, Carlier MF, Guittet E, van Heijenoort C. Coupling of folding and binding of thymosin beta4 upon interaction with monomeric actin monitored by nuclear magnetic resonance. J Biol Chem. 2004;279(22):23637-45.
15. Nemolato S, Cabras T, Cau F, Fanari MU, Fanni D, Manconi B, Messana I, Castagnola M, Faa G. Different thymosin Beta 4 immunoreactivity in foetal and adult gastrointestinal tract. PLoS One. 2010;5:e9111.
16. Nemolato S CT, Fanari MU, Cau F, Fanni D, Gerosa C, Manconi B, Messana I, Castagnola M, Faa G. Immuno-reactivity of thymosin beta 4 in human foetal and adult genitourinary tract. Eur J Histochem. 2010;54(4):e43.
17. Zoubek RE, Hannappel E. Subcellular distribution of thymosin beta4. Ann N Y Acad Sci. 2007;1112:442-50.
18. Huff T, Rosorius O, Otto AM, Muller CS, Ballweber E, Hannappel E, Mannherz HG. Nuclear localisation of the G-actin sequestering peptide thymosin beta4. J Cell Sci. 2004;117(Pt 22):5333-41.
19. Jo JO, Kim SR, Bae MK, Kang YJ, Ock MS, Kleinman HK, Cha HJ. Thymosin beta4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1alpha-dependent manner. Biochim Biophys Acta. 2010;1803(11):1244-51.
20. Jo JO KY, Ock MS, Kleinman HK, Chang HK, Cha HJ. Thymosin β4 expression in human tissues and in tumors using tissue microarrays. Appl Immunohistochem Mol Morphol. 2011;19(2):160-67.
21. Wang WS CP, Hsiao HL, Ju SY, Su Y. Overexpression of the thymosin beta-4 gene is associated with malignant progression of SW480 colon cancer cells. Oncogene. 2003;22(21):3297-306.
22. Wang WS CP, Hsiao HL, Wang HS, Liang WY, Su Y. Overexpression of the thymosin beta-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma. Oncogene. 2004;23(39):6666-71.
23. Wang ZY, Zeng FQ, Zhu ZH, Jiang GS, Lv L, Wan F, Dong R, Xiao XY, Xing SA. Evaluation of thymosin beta4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma. Urol Oncol. 2012;30(2):167-76.
24. Huang HC, Hu CH, Tang MC, Wang WS, Chen PM, Su Y. Thymosin beta4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase. Oncogene. 2007;26(19):2781-90.
25. Hsiao HL WW, Chen PM, Su Y. Overexpression of thymosin beta-4 renders SW480 colon carcinoma cells more resistant to apoptosis triggered by FasL and two topoisomerase II inhibitors via downregulating Fas and upregulating Survivin expression, respectively. Carcinogenesis. 2006;27(5):936-44.
26. Oh JM ME. Actin-sequestering protein, thymosin beta-4, induces paclitaxel resistance through ROS/HIF-1alpha stabilization in HeLa human cervical tumor cells. Life Sci. 2010;87(9-10):286-93.
27. Cha HJ, Jeong MJ, Kleinman HK. Role of thymosin beta4 in tumor metastasis and angiogenesis. J Natl Cancer Inst. 2003;95(22):1674-80.
28. Kielosto M, Nummela P, Jarvinen K, Yin M, Holtta E. Identification of integrins alpha6 and beta7 as c-Jun-and transformation-relevant genes in highly invasive fibrosarcoma cells. Int J Cancer. 2009.125(5):1065-73.
29. Kim A, Son M, Kim KI, Yang Y, Song EY, Lee HG, Lim JS. Elevation of intracellular cyclic AMP inhibits NF-kappaB-mediated thymosin beta4 expression in melanoma cells. Exp Cell Res. 2009;315(19):3325-35.
30. Kim NS, Kang YJ, Jo JO, Kim HY, Oh YR, Kim YO, Jung MH, Ock MS, Cha HJ. Elevated expression of thymosin beta4, vascular endothelial growth factor (VEGF), and hypoxia inducible factor (HIF)-1alpha in early-stage cervical cancers. Pathol Oncol Res. 2011;17(3):493-502.
31. Kobayashi T, Okada F, Fujii N, Tomita N, Ito S, Tazawa H, Aoyama T, Choi SK, Shibata T, Fujita H, Hosokawa M. Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am J Pathol. 2002;160(3):869-82.
32. Liu JM, Kusinski M, Ilic V, Bignon J, Hajem N, Komorowski J, Kuzdak K, Stepien H, Wdzieczak-Bakala J. Overexpression of the angiogenic tetrapeptide Ac-SDKP in human malignant tumors. Anticancer Res. 2008;28(5A):2813-7.
33. Ricci-Vitiani L, Mollinari C, di Martino S, Biffoni M, Pilozzi E, Pagliuca A, de Stefano MC, Circo R, Merlo D, De Maria R, Garaci E. Thymosin beta4 targeting impairs tumorigenic activity of colon cancer stem cells. FASEB J. 2010;24(11):4291-301.
34. Steiniger SC, Coppinger JA, Kruger JA, Yates J, 3rd, Janda KD. Quantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population. Stem Cells. 2008;26(12):3037-46.
35. Philp D, Goldstein AL, Kleinman HK. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev. 2004;125(2):113-15.
36. Smart N, Risebro CA, Clark JE, Ehler E, Miquerol L, Rossdeutsch A, Marber MS, Riley PR. Thymosin beta4 facilitates epicardial neovascularization of the injured adult heart. Ann N Y Acad Sci. 2010;1194:97-104.
37. Sosne G, Albeiruti AR, Hollis B, Siddiqi A, Ellenberg D, Kurpakus-Wheater M. Thymosin beta4 inhibits benzalkonium chloride-mediated apoptosis in corneal and conjunctival epithelial cells in vitro. Exp Eye Res. 2006;83(3):502-7.
38. Sosne G, Christopherson PL, Barrett RP, Fridman R. Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Invest Ophthalmol Vis Sc.i 2005;46(7):2388-95.
39. Sosne G, Hafeez S, Greenberry AL, 2nd, Kurpakus-Wheater M. Thymosin beta4 promotes human conjunctival epithelial cell migration. Curr Eye Res. 2002;24(4):268-73.
40. Sosne G, Qiu P, Goldstein AL, Wheater M. Biological activities of thymosin beta4 defined by active sites in short peptide sequences. FASEB J. 2010;24(7):2144-51.
41. Sosne G, Qiu P, Kurpakus-Wheater M, Matthew H. Thymosin beta4 and corneal wound healing: visions of the future. Ann N Y Acad Sci. 2010;1194:190-98.
42. Sosne G, Siddiqi A, Kurpakus-Wheater M. Thymosin-beta4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitro. Invest Ophthalmol Vis Sci. 2004;45(4):1095-100.
43. Leeanansaksiri W, DeSimone SK, Huff T, Hannappel E, Huff TF. Thymosin beta 4 and its N-terminal tetrapeptide, AcSDKP, inhibit proliferation, and induce dysplastic, non-apoptotic nuclei and degranulation of mast cells. Chem Biodivers. 2004;1(7):1091-100.
44. Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432(7016):466-72.
45. Qiu FY, Song XX, Zheng H, Zhao YB, Fu GS. Thymosin beta4 induces endothelial progenitor cell migration via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol. 2009;53(3):209-14.
46. Reyes-Gordillo K, Shah R, Popratiloff A, Fu S, Hindle A, Brody F, Rojkind M. Thymosin-beta4 (Tbeta4) blunts PDGF-dependent phosphorylation and binding of AKT to actin in hepatic stellate cells. Am J Pathol. 2011;178(5):2100-8.
47. Delbosc S, Haloui M, Louedec L, Dupuis M, Cubizolles M, Podust VN, Fung ET, Michel JB, Meilhac O. Proteomic analysis permits the identification of new bio-markers of arterial wall remodeling in hypertension. Mol Med. 2008;14(7-8):383-94.
48. Matsuo K, Akasaki Y, Adachi K, Zhang M, Ishikawa A, Jimi E, Nishihara T, Hosokawa R. Promoting effects of thymosin beta4 on granulation tissue and new bone formation after tooth extraction in rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Epub ahead of print.
49. Philp D, Scheremeta B, Sibliss K, Zhou M, Fine EL, Nguyen M, Wahl L, Hoffman MP, Kleinman HK. Thymosin beta4 promotes matrix metalloproteinase expression during wound repair. J Cell Physiol. 2006;208(1):195-200.
50. Shrivastava S, Srivastava D, Olson EN, DiMaio JM, Bock-Marquette I. Thymosin beta4 and cardiac repair. Ann N Y Acad Sci. 2010;1194:87-96.
51. Yang H, Cui GB, Jiao XY, Wang J, Ju G, You SW. Thymosin-beta4 attenuates ethanol-induced neurotoxicity in cultured cerebral cortical astrocytes by inhibiting apoptosis. Cell Mol Neurobiol. 2010;30(1):149-60.
52. Zhao Y, Qiu F, Xu S, Yu L, Fu G. Thymosin beta4 activates integrin-linked kinase and decreases endothelial progenitor cells apoptosis under serum deprivation. J Cell Physiol.
53. Abiko T, Sekino H. Functional roles of Phe of deacetyl-thymosin beta4 in the impaired blastogenic response of uraemic T-lymphocytes. Mediators Inflamm. 1997;6(1):64-68.
54. Choi HM, Lee YA, Yang HI, Yoo MC, Kim KS. Increased levels of thymosin beta4 in synovial fluid of patients with rheumatoid arthritis: association of thymosin beta4 with other factors that are involved in inflammation and bone erosion in joints. Int J Rheum Dis. 2011;14(4):320-24.
55. Qiu P, Wheater MK, Qiu Y, Sosne G. Thymosin beta4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK. FASEB J. 2011;25(6):1815-26.